Enliven Therapeutics Inc. (ELVN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
22.64
2.18 (10.65%)
At close: Jan 15, 2025, 1:54 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
PE Ratio | -6.87 | -2.71 | -2.85 | -16.22 | -11.05 | -22.86 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.00 | -1.33 | -1.64 | -15.12 | -5.31 | -9.85 | -16.69 |
P/FCF Ratio | -8.01 | -3.13 | -3.64 | -34.15 | -11.77 | -29.53 | -29.51 |
P/OCF Ratio | -8.03 | -3.19 | -3.68 | -36 | -11.85 | -29.53 | -29.51 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | -0.00 | -0.00 | -0.01 | n/a | n/a | -0.04 |
Quick Ratio | 10.28 | 8.00 | 19.24 | 88.35 | 7.29 | 4.21 | 12.38 |
Current Ratio | 10.28 | 8.00 | 19.24 | 88.35 | 7.29 | 4.21 | 12.38 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.29 | 0.49 | 0.58 | 0.93 | 0.48 | 0.43 | n/a |
Return on Assets (ROA) | -0.26 | -0.45 | -0.22 | -0.14 | -0.7 | -1.47 | n/a |
Return on Capital (ROIC) | -0.34 | -0.53 | -0.23 | -0.07 | -0.83 | -1.82 | -0.95 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |